Centocor Ortho Biotech, Schering-Plough get European approval for Simponi
Thursday, October 08, 2009 15:00 IST Kenilworth, New Jersey
Centocor Ortho Biotech Inc and Schering-Plough Corporation announced that the European Commission has approved Simponi (golimumab) as a once-monthly, subcutaneous therapy for the treatment of moderate-to-severe